Review examines tryptophan metabolism’s role in female reproduction

Tryptophan, the amino acid best known as a building block for serotonin, may be far more deeply involved in female reproductive health than previously recognized. A new review in the Chinese Medical Journal describes tryptophan metabolism as a hidden regulatory network connecting ovarian function, fertility, pregnancy, maternal well-being, and newborn development. The authors argue that the biological effects of tryptophan extend well beyond mood and nutrition, reaching into the molecular environment in which eggs mature, embryos implant, and maternal immune tolerance develops.

Tryptophan is an essential amino acid, meaning the human body cannot produce it in sufficient quantities and must obtain it from food. It is also the only amino acid containing an indole ring, a chemical structure that enables it to generate a wide range of biologically active compounds. Once absorbed, tryptophan is processed primarily through three interconnected routes: the kynurenine pathway, the serotonin pathway, and the indole pathway. Together, these routes produce metabolites involved in immune signaling, inflammation, oxidative balance, energy metabolism, gut communication, and nervous-system function.

The review presents these pathways as a biochemical network that can influence reproduction both indirectly and directly. Systemically, tryptophan-derived metabolites may alter inflammation, oxidative stress, metabolic health, and biological aging, all of which can affect the reproductive axis linking the brain, pituitary gland, and ovaries. Locally, the same metabolites can act within the ovarian microenvironment, influencing follicle growth, oocyte quality, granulosa-cell activity, and hormone production. According to the authors, reproductive dysfunction may emerge when the balance among the three pathways is disturbed rather than when tryptophan itself is simply too low or too high.

The serotonin pathway appears to have several protective roles in the ovary. Tryptophan is converted to serotonin through the enzyme tryptophan hydroxylase, and serotonin can subsequently contribute to the production of melatonin. These molecules may help protect oocytes and granulosa cells from oxidative damage, a form of cellular stress that can impair mitochondrial activity, disrupt chromosome segregation, and accelerate follicular decline. The review also links serotonin and melatonin signaling with follicular development and the secretion of reproductive hormones. Such findings suggest that the pathway could be relevant to the maintenance of ovarian function, although the precise effects may depend on tissue, dose, timing, and the metabolic condition of the individual.

The kynurenine pathway presents a more complicated picture. It is initiated mainly by indoleamine 2,3-dioxygenase, or IDO, and tryptophan 2,3-dioxygenase, an enzyme expressed largely in the liver. Inflammatory signals can stimulate IDO, redirecting tryptophan away from serotonin production and toward kynurenine and related metabolites. Some of these compounds may contribute to oxidative stress, immune imbalance, metabolic dysfunction, and ovarian aging. Yet the pathway is not inherently harmful. One of its final products is nicotinamide adenine dinucleotide, or NAD+, a central coenzyme required for cellular energy production, DNA repair, and stress responses. NAD+ availability has been associated with protection of the ovarian reserve, creating what the review describes as a double-edged biological system.

Metabolomic studies offer clues that these pathways may be altered in reproductive disorders. In women with diminished ovarian reserve, researchers have detected lower concentrations of tryptophan and several indole-related metabolites in follicular fluid, the specialized liquid surrounding developing oocytes. Because follicular fluid supplies nutrients and signaling molecules to the egg, changes in its chemical composition could influence oocyte maturation and developmental potential. In polycystic ovary syndrome, meanwhile, the kynurenine pathway appears to be abnormally activated. PCOS is characterized by hormonal imbalance, metabolic disturbances, and irregular ovulation, but the review emphasizes that more work is needed to determine whether altered tryptophan metabolism drives these features, results from them, or interacts with them in a feedback loop.

The third route, the indole pathway, highlights the increasingly important connection between the gut and the reproductive system. Intestinal microorganisms transform tryptophan into indole derivatives that can travel through the circulation and influence host physiology. Some of these compounds interact with the aryl hydrocarbon receptor, a sensor involved in barrier integrity, immune regulation, and inflammatory control. Through this gut–reproductive axis, changes in diet or the microbial community could potentially affect the maternal internal environment and, in turn, reproductive outcomes. The authors note that this pathway may help explain why metabolic health, intestinal inflammation, and reproductive function are often closely associated, even when the ovaries themselves are not the original site of disease.

Tryptophan metabolism also becomes especially important during pregnancy, when the mother’s immune system must tolerate the developing fetus without losing its ability to defend against infection. Local and systemic kynurenine signaling, including IDO activity, has been implicated in the establishment of maternal–fetal immune tolerance. Disruption of this balance may contribute to pregnancy complications such as preeclampsia, although the biological mechanisms remain under investigation. Tryptophan availability may also affect maternal psychological health through serotonin-related signaling, while maternal nutrition and metabolism can influence fetal brain development, immune maturation, and early-life physiology. These effects demonstrate why tryptophan should be viewed not only as a nutrient but also as a source of signals shared between mother, placenta, fetus, and microbiome.

The review outlines several possible therapeutic directions, including dietary strategies, manipulation of the gut microbiota, regulation of IDO and other metabolic enzymes, NAD+-supporting approaches, and melatonin-based antioxidant treatment. In theory, these interventions could be tailored to the specific pathway disrupted in a patient: enhancing protective serotonin or indole signals, reducing harmful inflammatory kynurenine activity, or restoring energy and repair mechanisms through NAD+. However, the authors stress that these possibilities remain largely theoretical. Much of the current evidence comes from animal models, metabolomic associations, or laboratory experiments rather than large randomized clinical trials. Tryptophan supplementation is not automatically safe or effective, particularly during pregnancy, and changing one pathway may unintentionally affect others.

By organizing existing evidence around the three metabolic pathways, ovarian function, the maternal internal environment, and maternal–infant health, the review offers a framework for investigating reproductive disorders at the intersection of metabolism, immunity, neuroscience, and microbiology. Its central message is that tryptophan metabolism may be a powerful but highly context-dependent regulator of female reproductive biology. Future studies will need to identify which metabolites act in particular ovarian or placental cell types, how their concentrations change across the menstrual cycle and pregnancy, and which patients could benefit from targeted intervention. If those questions can be answered, a molecule long associated with protein nutrition and serotonin could become a gateway to new strategies for protecting fertility, supporting healthier pregnancies, and improving reproductive care.

News Publication Date: 5 July 2026

Web References: https://doi.org/10.1097/CM9.0000000000004145

References: Chinese Medical Journal, “Tryptophan metabolism: A hidden regulator of female reproductive health beyond fertility,” DOI: 10.1097/CM9.0000000000004145